|
RPL8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.11359999996641E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.27139999999993E-05 |
| Normal-vs-Stage2 |
1.051170E-01 |
| Normal-vs-Stage3 |
1.208010E-04 |
| Normal-vs-Stage4 |
1.784380E-04 |
| Stage1-vs-Stage2 |
4.649000E-01 |
| Stage1-vs-Stage3 |
4.659400E-01 |
| Stage1-vs-Stage4 |
1.492020E-01 |
| Stage2-vs-Stage3 |
2.593800E-01 |
| Stage2-vs-Stage4 |
1.295610E-01 |
| Stage3-vs-Stage4 |
4.716800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.82810000002054E-06 |
| Normal-vs-AfricanAmerican |
3.069900E-02 |
| Normal-vs-Asian |
8.010000E-04 |
| Caucasian-vs-AfricanAmerican |
8.543400E-01 |
| Caucasian-vs-Asian |
3.516800E-01 |
| AfricanAmerican-vs-Asian |
4.866400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.44130000000609E-05 |
| Normal-vs-Female |
1.93048000000084E-05 |
| Male-vs-Female |
8.468800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.7102899999899E-05 |
| Normal-vs-Age(41-60Yrs) |
3.005200E-04 |
| Normal-vs-Age(61-80Yrs) |
1.096940E-03 |
| Normal-vs-Age(81-100Yrs) |
9.180400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.949400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.432400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.586600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.328800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.046400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.674400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.138200E-01 |
| Classical-VS-Follicular |
5.147700E-02 |
| Classical-VS-Other |
6.969000E-01 |
| Classical-VS-Normal |
1.03740000001462E-06 |
| Tall-VS-Follicular |
7.205700E-02 |
| Tall-VS-Other |
8.921200E-01 |
| Tall-VS-Normal |
2.801600E-04 |
| Follicular-VS-Other |
3.476400E-01 |
| Follicular-VS-Normal |
7.614500E-02 |
| Other-VS-Normal |
1.072350E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.90120000000049E-05 |
| Normal-vs-N1 |
1.436680E-03 |
| N0-vs-N1 |
5.110600E-01 |
|
|
